Autopsy report · NCT01148056
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Cause of deathSlow enrollment
“The study was closed to enrollment due to slow accrual.”
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 4 years 1 month before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 2 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Rectal Cancer
- Interventions
- Intensity Modulated Radiation Therapy
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
“Study closed due to slow enrollment.” - A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
“Study closed to enrollment due to low accrual.” - Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
“The study was halted because enrollment was too slow” - COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
“The study was closed due to continued enrollment hurdles.” - Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
“accrual was slow and sporadic so the study was closed”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.